/Companies

Aramune Technologies

Belfast, GB · 5 known investors

Find your way into Aramune Technologies

Sign up to see every warm intro you have to Aramune Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Aramune Technologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Aramune develops pharmaceutical and nutraceutical products targeting diseases including diabetes, obesity, cardiovascular disease, and neurodegenerative conditions. The company builds on molecular nutrition research to create treatments for the healthcare market.

Founders & leadership

B
BrianProfessor of Molecular Nutrition
CNChris Nicklin
Chris Nicklin

Board

S
Stuart

Investors · 5

Also in the syndicate · 3

Co-Fund NIleadQUBIS Innovation FundSapphire Capital Partners

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Aramune Technologies do?
Aramune develops pharmaceutical and nutraceutical products targeting diseases including diabetes, obesity, cardiovascular disease, and neurodegenerative conditions. The company builds on molecular nutrition research to create treatments for the healthcare market.
Who founded Aramune Technologies?
Aramune Technologies was founded by Brian, Chris Nicklin.
Who are Aramune Technologies's investors?
Aramune Technologies's investors include Clarendon Fund Managers Ltd., QUBIS.
Where is Aramune Technologies headquartered?
Aramune Technologies is headquartered in Belfast, GB.